Ruth Oratz

Biosketch / Results /

Ruth Oratz, M.D.

Clinical Professor; Firm Chief Dept of Medicine
Department of Medicine (Medicine)

Clinical Addresses

345 EAST 37TH ST., SUITE 202
NEW YORK, NY 10016
Hours: Mon. 9:30 - 4:30; Tue. 9:30 - 4:30; Wed. 9:30 - 4:30; Thu. 9:30 - 4:30; Fri. 9:30 - 4:30
Handicap Access: yes
Phone: 212-400-4904
Fax: 212-400-4908

« Back to Results

Medical Specialties

Cancer, Medical Oncology

Medical Expertise

Gynecologic Oncology, Cancer Prevention, Breast Cancer

Clinical Responsibilities

Dr. Oratz specializes in treating women with breast cancer and other malignancies, and those at high risk for cancer. Her practice focuses on helping the woman with cancer continue to live her life actively and fully, placing significant attention on flexible treatment programs, and those that address women's concerns about career, family life, relationships and sexuality. She has been in practice since 1988. Dr. Oratz conducts clinical trials and is actively involved in breast cancer research.

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, Cigna HMO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP HMO, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MULTIPLAN/PHCS PPO, NYS EMPIRE PLAN, OXFORD FREEDOM, Oxford Medicare, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER, UPN Elite

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

1985 — Ab Internal Medicine - Internal Medicine
1989 — Ab Internal Medicine (Medical Oncology)

Education

1978-1982 — Albert Einstein College of Medicine, Medical Education
1982-1985 — Bellevue Hospital Center (Medical Oncology), Residency Training
1985-1988 — NYU Medical Center (Hematology/Oncology), Clinical Fellowships

« Back to Results

Research Interests

Breast Cancer Cancer Genetics Female Malignancies Women's Health

Research Keywords

melanoma; colony-stimulating factor; melanoma vaccine

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Novel combination of toll-like receptor (TLR)-7 agonist imiquimod and local radiotherapy in the treatment of breast cancer chest wall recurrences or skin metastases
Janosky, M D; Demaria, S; Novik, Y; Oratz, R; Tiersten, A; Goldberg, J D; Wang, E; Marincola, F; Formenti, S; Adams, S
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 451782, year: 2013, vol: 31, page: , stat: Journal Article,

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation
Rinella, Erica S; Shao, Yongzhao; Yackowski, Lauren; Pramanik, Sreemanta; Oratz, Ruth; Schnabel, Freya; Guha, Saurav; Leduc, Charles; Campbell, Christopher L; Klugman, Susan D; Terry, Mary Beth; Senie, Ruby T; Andrulis, Irene L; Daly, Mary; John, Esther M; Roses, Daniel; Chung, Wendy K; Ostrer, Harry
2013 Jan;:174-182, Human genetics
— id: 222102, year: 2013, vol: , page: 174, stat: Journal Article,

Novel Combination of Toll-Like Receptor (TLR)-7 Agonist Imiquimod and Local Radiation Therapy in the Treatment of Metastatic Breast Cancer Involving the Skin or Chest Wall
Vatner, R. ; Demaria, S. ; Fenton-Kerimian, M. ; Novik, Y. ; Oratz, R. ; Tiersten, A. ; Goldberg, J. D. ; Adams, S. ; Formenti, S.
2013 OCT 1;87(2 S S):S111-S111, International journal of radiation oncology biology physics
— id: 657332, year: 2013, vol: 87, page: S111, stat: Journal Article,

Minimal Acute Toxicity Associated With Concurrent Adjuvant Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer
Vatner, R.; Fenton-Kerimian, M.; Novik, Y.; Volm, M.; Tiersten, A.; Oratz, R.; Speyer, J.; Formenti, S. C.
2012 NOV 1;84(3 S S):S251-S251, International journal of radiation oncology biology physics
— id: 204692, year: 2012, vol: 84, page: S251, stat: Journal Article,

Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer
Oratz, Ruth; Kim, Benjamin; Chao, Calvin; Skrzypczak, Stanley; Ory, Caron; Bugarini, Roberto; Broder, Michael
2011 Mar;7(2):94-99, Journal of Oncology Practice
— id: 134927, year: 2011, vol: 7, page: 94, stat: Journal Article,

Cost-Effectiveness of 21-gene assay in node-positive, early-stage breast cancer
Vanderlaan, Burton F; Broder, Michael S; Chang, Eunice Y; Oratz, Ruth; Bentley, Tanya G K
2011 ;17(7):455-464, American journal of managed care
— id: 136489, year: 2011, vol: 17, page: 455, stat: Journal Article,

Living with metastatic breast cancer: A global patient survey
Mayer M.; Hunis A.; Oratz R.; Glennon C.; Spicer P.; Caplan E.; Fallowfield L.
2010 ;7(9):406-412, Community Oncology
— id: 115286, year: 2010, vol: 7, page: 406, stat: Journal Article,

Cardiac Safety Results of a Phase II Trial of Adjuvant Docetaxel/Cyclophosphamide Plus Trastuzumab (Her TC) in HER2+Early Stage Breast Cancer Patients
Jones, SE; Collea, RP; Oratz, R; Paul, D; Sedlacek, SM; Holmes, FA; Portillo, RM; Crockett, MW; Wang, Y; Asmar, L; O'Shaughnessy, JA; Robert, NJ
2009 DEC 15 ;69(24):792S-792S, Cancer research
— id: 106457, year: 2009, vol: 69, page: 792S, stat: Journal Article,

Evaluating the needs of women living with metastatic breast cancer: A global survey
Mayer, M; Hunis, A; Oratz, R; Glennon, C; Spicer, P; Caplan, E; Fallowfield, L
2009 MAR ;18(1):S70-S70, Breast
— id: 99257, year: 2009, vol: 18, page: S70, stat: Journal Article,

Importance of Providing Tailored Resources to Patients with Metastatic Breast Cancer: Results of the Global BRIDGE Survey
Mayer, M; Hunis, A; Oratz, R; Glennon, C; Spicer, P; Caplan, E; Fallowfield, L
2009 DEC 15 ;69(24):674S-674S, Cancer research
— id: 106454, year: 2009, vol: 69, page: 674S, stat: Journal Article,

Effect of 21-Gene Recurrence Score Results on Treatment Recommendations in Patients with Lymph Node-Positive, Estrogen Receptor-Positive Breast Cancer
Oratz, R; Chao, C; Skrzypczak, S; Kim, B; Broder, M
2009 DEC 15 ;69(24):602S-602S, Cancer research
— id: 106453, year: 2009, vol: 69, page: 602S, stat: Journal Article,

Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer
Andreopoulou, Eleni; Gaiotti, Darci; Kim, Eugene; Volm, Matthew; Oratz, Ruth; Freedberg, Robin; Downey, Andrea; Vogel, Charles L; Chia, Stephen; Muggia, Franco
2007 Aug;7(9):690-696, Clinical breast cancer
— id: 75388, year: 2007, vol: 7, page: 690, stat: Journal Article,

Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer
Oratz, Ruth; Paul, Dev; Cohn, Allen L; Sedlacek, Scot M
2007 Jul;3(4):182-186, Journal of Oncology Practice
— id: 112565, year: 2007, vol: 3, page: 182, stat: Journal Article,

BRCA1 and BRCA2 mutations: 185delAG, 5382insC and 6174deIT; Ashkenazi founder or Jewish determinant?
Bersson, Y; Pearlman, A; Shajahan, S; Ostrer, H; Oratz, R
2006 FEB ;100(2):S180-S181, Breast cancer research & treatment
— id: 71009, year: 2006, vol: 100, page: S180, stat: Journal Article,

Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy
Demaria S; Volm MD; Shapiro RL; Yee HT; Oratz R; Formenti SC; Muggia F; Symmans WF
2001 Oct;7(10):3025-3030, Clinical cancer research
— id: 24141, year: 2001, vol: 7, page: 3025, stat: Journal Article,

Increase in the lymphocytic infiltrate in breast cancer after neoadjuvant paclitaxel chemotherapy
Demaria, Sandra; Volm, M. D.; Shapiro, R. L.; Yee, H. T.; Oratz, R.; Formenti, S.; Muggia, F.; Symmans, W. F.
2000 ;43(41):334-334, Proceedings (American Association for Cancer Research)
— id: 109238, year: 2000, vol: 43, page: 334, stat: Journal Article,

Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment
Symmans WF; Volm MD; Shapiro RL; Perkins AB; Kim AY; Demaria S; Yee HT; McMullen H; Oratz R; Klein P; Formenti SC; Muggia F
2000 Dec;6(12):4610-4617, Clinical cancer research
— id: 22642, year: 2000, vol: 6, page: 4610, stat: Journal Article,

Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine
Reynolds SR; Oratz R; Shapiro RL; Hao P; Yun Z; Fotino M; Vukmanovic S; Bystryn JC
1997 Sep 17;72(6):972-976, International journal of cancer
— id: 12259, year: 1997, vol: 72, page: 972, stat: Journal Article,

IMPROVED SURVIVAL OF MELANOMA PATIENTS WITH DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO MELANOMA VACCINE IMMUNIZATION
BYSTRYN, JC; ORATZ, R; ROSES, DF; HARRIS, MN; HENN, M; LEW, R
1991 APR ;96(4):549-549, Journal of investigative dermatology
— id: 51638, year: 1991, vol: 96, page: 549, stat: Journal Article,